SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001773427-22-000013
Filing Date
2022-02-24
Accepted
2022-02-24 06:51:48
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K swtx-20220224.htm   iXBRL 8-K 37612
2 EX-99.1 q4-earningsrelease.htm EX-99.1 77068
6 GRAPHIC springworkslogojpega.jpg GRAPHIC 8674
  Complete submission text file 0001773427-22-000013.txt   274852

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20220224.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20220224_lab.xml EX-101.LAB 23896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20220224_pre.xml EX-101.PRE 12602
8 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20220224_htm.xml XML 11284
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 22666443
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences